Civic Intelligence

Pharmacotherapy Publications Inc

990 • Fiscal year 2014 • EIN 04-2720360

Jan 01, 2014 to Dec 31, 2014 • Filed on Oct 13, 2015

Organization ProfileWWW.PHARMACOTHERAPY.ORG

View Organization Page

13000 West 87th Street ParkwayLenexa, KS 66215

(913) 492-3311

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

32nd percentile

0.02x

Higher debt load relative to assets than 32% of similar nonprofits.

2014 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2014

Liabilities / Revenue

43rd percentile

0.08x

Higher debt load relative to revenue than 43% of similar nonprofits.

2014 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2014

Net Margin

90th percentile

43%

Higher net margin than 90% of similar nonprofits.

2014 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2014

Top Officer Pay

34th percentile

$0

Higher top officer pay than 34% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2014 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2014

Asset Growth

79th percentile

17%

Faster asset growth than 79% of similar nonprofits.

2014 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2013 to 2014

Revenue Growth

50th percentile

3.8%

Faster revenue growth than 50% of similar nonprofits.

2014 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2013 to 2014

Balance Sheet
Liabilities / Assets32nd percentile

Assets

Up

$1,214,923

Up $173,429 (+17%) from 2013

Net Assets

Up

$1,184,923

Up $152,929 (+15%) from 2013

Liabilities

Up

$30,000

Up $20,500 (+216%) from 2013

Revenue And Expenses
Liabilities / Revenue43rd percentileNet Margin90th percentile

Revenue

Up

$389,894

Up $14,208 (+3.8%) from 2013

Expenses

Up

$221,393

Up $23,039 (+12%) from 2013

Net Income

Down

$168,501

Down $8,831 (-5.0%) from 2013

Historical Trend

Balance Sheet Trend

Asset Growth79th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$6.0M$4.0M$2.0M$0Assets 2010: $1,239,045Liabilities 2010: $188,429Net Assets 2010: $1,050,6162010Assets 2011: $1,082,574Liabilities 2011: $48,630Net Assets 2011: $1,033,9442011Assets 2012: $892,073Liabilities 2012: $98,983Net Assets 2012: $793,0902012Assets 2013: $1,041,494Liabilities 2013: $9,500Net Assets 2013: $1,031,9942013Assets 2014: $1,214,923Liabilities 2014: $30,000Net Assets 2014: $1,184,9232014Assets 2015: $1,238,395Liabilities 2015: $14,589Net Assets 2015: $1,223,8062015Assets 2016: $1,370,536Liabilities 2016: $20,739Net Assets 2016: $1,349,7972016Assets 2017: $1,637,402Liabilities 2017: $253,002Net Assets 2017: $1,384,4002017Assets 2018: $1,415,161Liabilities 2018: $218,665Net Assets 2018: $1,196,4962018Assets 2019: $1,510,021Liabilities 2019: $185,942Net Assets 2019: $1,324,0792019Assets 2020: $1,613,717Liabilities 2020: $147,715Net Assets 2020: $1,466,0022020Assets 2021: $1,752,757Liabilities 2021: $119,779Net Assets 2021: $1,632,9782021Assets 2022: $1,471,268Liabilities 2022: $99,821Net Assets 2022: $1,371,4472022Assets 2023: $1,560,881Liabilities 2023: $65,744Net Assets 2023: $1,495,1372023Assets 2024: $5,236,664Liabilities 2024: $229,370Net Assets 2024: $5,007,2942024

Highlighted filing

2014

Assets$1,214,923
Liabilities$30,000
Net Assets$1,184,923
Open 2014 Filing

Operations Trend

Revenue Growth50th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.5M$1.0M$500K$0-$500KExpenses 2010: $981,3312010Expenses 2011: $1,002,8852011Revenue 2012: $421,035Expenses 2012: $701,815Net Income 2012: -$280,7802012Revenue 2013: $375,686Expenses 2013: $198,354Net Income 2013: $177,3322013Revenue 2014: $389,894Expenses 2014: $221,393Net Income 2014: $168,5012014Revenue 2015: $347,414Expenses 2015: $252,468Net Income 2015: $94,9462015Revenue 2016: $452,882Expenses 2016: $298,818Net Income 2016: $154,0642016Revenue 2017: $392,636Expenses 2017: $380,862Net Income 2017: $11,7742017Revenue 2018: $405,982Expenses 2018: $433,446Net Income 2018: -$27,4642018Revenue 2019: $384,308Expenses 2019: $444,198Net Income 2019: -$59,8902019Revenue 2020: $371,617Expenses 2020: $346,666Net Income 2020: $24,9512020Revenue 2021: $429,740Expenses 2021: $401,086Net Income 2021: $28,6542021Revenue 2022: $429,590Expenses 2022: $434,953Net Income 2022: -$5,3632022Revenue 2023: $406,984Expenses 2023: $475,737Net Income 2023: -$68,7532023Revenue 2024: $648,554Expenses 2024: $581,263Net Income 2024: $67,2912024

Highlighted filing

2014

Revenue$389,894
Expenses$221,393
Net Income$168,501
Open 2014 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2014 to Dec 31, 2014
Signed
Oct 13, 2015
Return Version
2014v5.0
Gross Receipts
$712,860
Mission and Program Overview

Mission

The organization's primary mission is to serve subscribers and the general public with education, review and publication of research and study results of drugs and the interaction of pharmaceuticals.

Balance Sheet Detail
LineBeginningEndChange
Assets
Investments Other Securities$796,690$843,961▲ $47,271
Cash and Non-Interest-Bearing Accounts$200,213$270,502▲ $70,289
Savings and Temporary Cash Investments$44,591$100,460▲ $55,869
Total Assets$1,041,494$1,214,923▲ $173,429
Liabilities
Accounts Payable and Accrued Expenses$9,500$30,000▲ $20,500
Total Liabilities$9,500$30,000▲ $20,500
Net Assets / Fund Balance
Unrestricted Net Assets$1,031,994$1,184,923▲ $152,929
Total Net Assets Fund Balance$1,031,994$1,184,923▲ $152,929
Total Liabilities and Net Assets / Fund Balance$1,041,494$1,214,923▲ $173,429

Asset Categories

AssetBook ValueDepreciationBasis
Other Securities$843,961--
Compensation and Service Providers
Top Officer Pay34th percentile

Board Members and Trustees

NameTitle
Michael S Maddux Pharmd FccpBoard Chair
Edith Nutescupharmdfccp BcpsDirector
Jerry L Bauman Pharmdfccp BcpsDirector
Terry L Schwinghammer Pharm D FccpDirector
William a MillerDirector
Susan FaganFormer Direc
Revenue and Support

Revenue Composition

Contributions and Grants
$0
Program Service Revenue
$322,192
Investment Income
$67,702
Other Revenue
$0
Change in Net Assets
$168,501

Audited Revenue Reconciliation

Revenue per Audited Statements
$384,904
Revenue Not Reported on Financial Statements
$4,990
Revenue Not Reported on Form 990
$-15,572
Total Revenue per Audited Statements
$369,332
Total Revenue per Form 990
$389,894
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$221,393
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Fees for Services Other$143,670$60,520-$204,190
Fees for Services Accounting-$10,429-$10,429
Fees for Service Investment Mgmnt Fees-$4,990-$4,990
Fees for Services Legal-$135-$135
Other Expenses$746$125-$125
Travel$90--$90
Total Functional Expenses$144,506$76,887$0$221,393

Audited Expense Reconciliation

Line ItemAmount
Total Expenses per Form 990$221,393
Expenses per Audited Statements$216,403
Total Expenses per Audited Statements$216,403
Expenses Not Reported on Financial Statements$4,990
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
Yes
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Page 6, Part VI, Line 11B

“The return will be reviewed by the full board of directors. A copy of the return will be maintained for public inspection.”

Form 990, Page 6, Part VI, Line 12C

“The organization regularly monitors ongoing or proposed transactions for conflicts of interest as it relates to the board of directors. The policy prohibits participation and deliberation and decision making of any board member as it relates to a conflict.”

Form 990, Page 6, Part VI, Line 19

“Governing documents are available for public inspection upon request and posted on the secretary of state website of the commonwealth of massachussets.”

Filing and Contact Details

Filer

Filer Name
Pharmacotherapy Publications Inc
EIN
04-2720360
Phone
9134923311
Address
13000 WEST 87TH STREET PARKWAY, LENEXA, KS 66215

Signing Officer

Name
Michael S Maddux
Title
Executive Director
Phone
9134923311
Signed
2015-10-13

Organization Details

Principal Officer
Michael S Maddux
Formed
1981
Legal Domicile
Ma
Voting Board Members
5
Independent Board Members
4
Employees
0

Preparer

Firm
Bridgebuilder Tax Legal Services Pa
Address
9325 PFLUMM RD, LENEXA, KS 66215-3347
Preparer
Kenneth L Cox
Phone
9134926008
Supplemental Narrative

Additional Explanations

Form 990, Part IX, Line 11G

“Manuscript scientific editing 13,100 0 0 original manuscript fees 42,000 0 0 manuscript scholar one 4,455 0 0 development editor & consulti 24,115 0 0 consulting 60,000 0 0 board of directors 0 60,520 0”

Form 990, Part XI, Line 9

“Other income 0 voided checks net with program expenses 0”

Financial Statement Notes

Schedule D, Page 3, Part X

“Uncertain tax provisions, if any, are recorded in accordance with financial accounting standards board (fasb) accounting standards codification (asc) 740, income taxes, which require the recognition of a liability for tax positions taken that do not meet the more-likely-than-not standard that the position will be sustained upon examination by the taxing authorities. There is no liability for uncertain tax positions recorded at december 31. The organization's income tax filings are subject to examination by various taxing authorities. The organization's open examination periods are 2011 and forward.”

Schedule D, Page 4, Part XI, Line 2D

“OTHER INCOME 0”

Schedule D, Page 4, Part XII, Line 2D

“Voided checks net with program expenses 0”

Raw XML Appendix384 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0true
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt09500
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt030000
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0THE ORGANIZATION'S PRIMARY MISSION IS TO SERVE SUBSCRIBERS AND THE GENERAL PUBLIC WITH EDUCATION, REVIEW AND PUBLICATION OF RESEARCH AND STUDY RESULTS OF DRUGS AND THE INTERACTION OF PHARMACEUTICALS.
IRS990/AnnualDisclosureCoveredPrsnInd0true
IRS990/AuditCommitteeInd0true
IRS990/BackupWthldComplianceInd0true
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0ACCP-PHARMACOTHERAPY PUBLICATIONS
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine2Txt0INC
IRS990/BooksInCareOfDetail/PhoneNum09134923311
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt013000 WEST 87TH STREET PARKWAY
IRS990/BooksInCareOfDetail/USAddress/CityNm0LENEXA
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0KS
IRS990/BooksInCareOfDetail/USAddress/ZIPCd066215
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOfficerEntInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt0200213
IRS990/CashNonInterestBearingGrp/EOYAmt0270502
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CollectionsOfArtInd0false
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0false
IRS990/CompensationProcessOtherInd0false
IRS990/ConflictOfInterestPolicyInd0true
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt00
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt067702
IRS990/CYOtherExpensesAmt0221393
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt0322192
IRS990/CYRevenuesLessExpensesAmt0168501
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt0221393
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0389894
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/Desc0SUBSCRIPTION SUPPLEMENTS AND PUBLICATION SUBSCRIPTIONS - SUBSCRIPTION INCOME FROM PUBLISHING A SCIENTIFIC JOURNAL MONTHLY THAT WILL EVALUATE DRUGS, DRUG TREATMENT, AND PUBLISH CLINICAL RESEARCH ARTICLES.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0true
IRS990/DonorAdvisedFundInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/ExpenseAmt0144506
IRS990/FamilyOrBusinessRlnInd0false
IRS990/FederalGrantAuditRequiredInd0false
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt010429
IRS990/FeesForServicesAccountingGrp/TotalAmt010429
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt0135
IRS990/FeesForServicesLegalGrp/TotalAmt0135
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt060520
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt0143670
IRS990/FeesForServicesOtherGrp/TotalAmt0204190
IRS990/FeesForSrvcInvstMgmntFeesGrp/ManagementAndGeneralAmt04990
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt04990
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignOfficeInd0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt02.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt32.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/PersonNm0MICHAEL S MADDUX PHARMD FCCP
IRS990/Form990PartVIISectionAGrp/PersonNm1WILLIAM A MILLER
IRS990/Form990PartVIISectionAGrp/PersonNm2JERRY L BAUMAN PHARMDFCCP BCPS
IRS990/Form990PartVIISectionAGrp/PersonNm3EDITH NUTESCUPHARMDFCCP BCPS
IRS990/Form990PartVIISectionAGrp/PersonNm4TERRY L SCHWINGHAMMER PHARM D FCCP
IRS990/Form990PartVIISectionAGrp/PersonNm5SUSAN FAGAN
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/TitleTxt0BOARD CHAIR
IRS990/Form990PartVIISectionAGrp/TitleTxt1DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5FORMER DIREC
IRS990/Form990ProvidedToGvrnBodyInd0true
IRS990/FormationYr01981
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/GainOrLossGrp/SecuritiesAmt033790
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt05
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt0356756
IRS990/GrossReceiptsAmt0712860
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0true
IRS990/IndependentAuditFinclStmtInd0true
IRS990/IndependentVotingMemberCnt04
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIXInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InvestmentIncomeGrp/ExclusionAmt033912
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt033912
IRS990/InvestmentInJointVentureInd0false
IRS990/InvestmentsOtherSecuritiesGrp/BOYAmt0796690
IRS990/InvestmentsOtherSecuritiesGrp/EOYAmt0843961
IRS990/IRPDocumentCnt09
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0MA
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt0322966
IRS990/LoanOutstandingInd0false
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0THE ORGANIZATION'S PRIMARY MISSION IS TO SERVE SUBSCRIBERS AND THE GENERAL PUBLIC WITH EDUCATION, REVIEW AND PUBLICATION OF RESEARCH AND STUDY RESULTS OF DRUGS AND THE INTERACTION OF PHARMACEUTICALS.
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt01031994
IRS990/NetAssetsOrFundBalancesEOYAmt01184923
IRS990/NetGainOrLossInvestmentsGrp/RelatedOrExemptFuncIncomeAmt033790
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt033790
IRS990/NetUnrlzdGainsLossesInvstAmt0-15572
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd0false
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OtherExpensesGrp/Desc0PAYROLL EXPENSE
IRS990/OtherExpensesGrp/Desc1PHONE/CONFERENCE CALLS
IRS990/OtherExpensesGrp/Desc2SUPPLIES
IRS990/OtherExpensesGrp/Desc3MISCELLANEOUS
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt0546
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt1142
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt2125
IRS990/OtherExpensesGrp/ProgramServicesAmt0746
IRS990/OtherExpensesGrp/TotalAmt0746
IRS990/OtherExpensesGrp/TotalAmt1546
IRS990/OtherExpensesGrp/TotalAmt2142
IRS990/OtherExpensesGrp/TotalAmt3125
IRS990/OtherWebsiteInd0X
IRS990/PartialLiquidationInd0false
IRS990/PoliticalCampaignActyInd0false
IRS990/PrincipalOfficerNm0MICHAEL S MADDUX
IRS990/ProfessionalFundraisingInd0false
IRS990/ProgramServiceRevenueGrp/Desc0SUBSCRIPTION CONTRACT
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt0322192
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt0322192
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYExcessBenefitTransInd0false
IRS990/PYInvestmentIncomeAmt044855
IRS990/PYOtherExpensesAmt0169551
IRS990/PYProgramServiceRevenueAmt0330831
IRS990/PYRevenuesLessExpensesAmt0177332
IRS990/PYSalariesCompEmpBnftPaidAmt028803
IRS990/PYTotalExpensesAmt0198354
IRS990/PYTotalRevenueAmt0375686
IRS990/ReconcilationRevenueExpnssAmt0168501
IRS990/RegularMonitoringEnfrcInd0true
IRS990/RelatedEntityInd0true
IRS990/RelatedOrganizationCtrlEntInd0true
IRS990/ReportInvestmentsOtherSecInd0true
IRS990/ReportLandBuildingEquipmentInd0false
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0false
IRS990/ReportProgramRelatedInvstInd0false
IRS990/RevenueAmt0322192
IRS990/SavingsAndTempCashInvstGrp/BOYAmt044591
IRS990/SavingsAndTempCashInvstGrp/EOYAmt0100460
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt033912
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt023921
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus2YearsAmt086294
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus3YearsAmt017537
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus4YearsAmt021181
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt0182845
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt0322192
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt0330831
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt0404296
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt0786159
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt0813754
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt02657232
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt033912
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt023921
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus2YearsAmt086294
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus3YearsAmt017537
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus4YearsAmt021181
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt0182845
IRS990ScheduleA/InvestmentIncomeCYPct00.06000
IRS990ScheduleA/InvestmentIncomePYPct00.06000
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.93560
IRS990ScheduleA/PublicSupportPY509Pct00.94360
IRS990ScheduleA/PublicSupportTotal509Amt02657232
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt0322192
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt0330831
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt0404296
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt0786159
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt0813754
IRS990ScheduleA/Total509Grp/TotalAmt02657232
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt0356104
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt0354752
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt0490590
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt0803696
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt0834935
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt02840077
IRS990/ScheduleBRequiredInd0false
IRS990ScheduleD/ExpensesNotRptFinclStmtAmt04990
IRS990ScheduleD/ExpensesSubtotalAmt0216403
IRS990ScheduleD/FootnoteTextInd0X
IRS990ScheduleD/InvestmentExpensesNotIncld2Amt04990
IRS990ScheduleD/InvestmentExpensesNotIncldAmt04990
IRS990ScheduleD/NetUnrealizedGainsInvstAmt0-15572
IRS990ScheduleD/OtherSecuritiesGrp/BookValueAmt0843961
IRS990ScheduleD/OtherSecuritiesGrp/Desc0BANK OF BLUE VALLEY - PUBLICLY TRADE
IRS990ScheduleD/OtherSecuritiesGrp/MethodValuationCd0F
IRS990ScheduleD/RevenueNotReportedAmt0-15572
IRS990ScheduleD/RevenueNotReportedFinclStmtAmt04990
IRS990ScheduleD/RevenueSubtotalAmt0384904
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt0UNCERTAIN TAX PROVISIONS, IF ANY, ARE RECORDED IN ACCORDANCE WITH FINANCIAL ACCOUNTING STANDARDS BOARD (FASB) ACCOUNTING STANDARDS CODIFICATION (ASC) 740, INCOME TAXES, WHICH REQUIRE THE RECOGNITION OF A LIABILITY FOR TAX POSITIONS TAKEN THAT DO NOT MEET THE MORE-LIKELY-THAN-NOT STANDARD THAT THE POSITION WILL BE SUSTAINED UPON EXAMINATION BY THE TAXING AUTHORITIES. THERE IS NO LIABILITY FOR UNCERTAIN TAX POSITIONS RECORDED AT DECEMBER 31. THE ORGANIZATION'S INCOME TAX FILINGS ARE SUBJECT TO EXAMINATION BY VARIOUS TAXING AUTHORITIES. THE ORGANIZATION'S OPEN EXAMINATION PERIODS ARE 2011 AND FORWARD.
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt1OTHER INCOME 0
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt2VOIDED CHECKS NET WITH PROGRAM EXPENSES 0
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc0SCHEDULE D, PAGE 3, PART X
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc1SCHEDULE D, PAGE 4, PART XI, LINE 2D
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc2SCHEDULE D, PAGE 4, PART XII, LINE 2D
IRS990ScheduleD/TotalBookValueSecuritiesAmt0843961
IRS990ScheduleD/TotalExpensesPerForm990Amt0221393
IRS990ScheduleD/TotalRevenuePerForm990Amt0389894
IRS990ScheduleD/TotalRevEtcAuditedFinclStmtAmt0369332
IRS990ScheduleD/TotExpnsEtcAuditedFinclStmtAmt0216403
IRS990/ScheduleJRequiredInd0false
IRS990/ScheduleORequiredInd0true
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0THE RETURN WILL BE REVIEWED BY THE FULL BOARD OF DIRECTORS. A COPY OF THE RETURN WILL BE MAINTAINED FOR PUBLIC INSPECTION.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1THE ORGANIZATION REGULARLY MONITORS ONGOING OR PROPOSED TRANSACTIONS FOR CONFLICTS OF INTEREST AS IT RELATES TO THE BOARD OF DIRECTORS. THE POLICY PROHIBITS PARTICIPATION AND DELIBERATION AND DECISION MAKING OF ANY BOARD MEMBER AS IT RELATES TO A CONFLICT.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2GOVERNING DOCUMENTS ARE AVAILABLE FOR PUBLIC INSPECTION UPON REQUEST AND POSTED ON THE SECRETARY OF STATE WEBSITE OF THE COMMONWEALTH OF MASSACHUSSETS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3MANUSCRIPT SCIENTIFIC EDITING 13,100 0 0 ORIGINAL MANUSCRIPT FEES 42,000 0 0 MANUSCRIPT SCHOLAR ONE 4,455 0 0 DEVELOPMENT EDITOR & CONSULTI 24,115 0 0 CONSULTING 60,000 0 0 BOARD OF DIRECTORS 0 60,520 0
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4OTHER INCOME 0 VOIDED CHECKS NET WITH PROGRAM EXPENSES 0
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990, PAGE 6, PART VI, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PAGE 6, PART VI, LINE 12C
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PAGE 6, PART VI, LINE 19
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PART IX, LINE 11G
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PART XI, LINE 9
IRS990ScheduleR/AssetExchangeInd0false
IRS990ScheduleR/AssetPurchaseFromOtherOrgInd0false
IRS990ScheduleR/AssetSaleToOtherOrgInd0false
IRS990ScheduleR/DivRelatedOrganizationInd0false
IRS990ScheduleR/GiftGrntCapContriFromOthOrgInd0false
IRS990ScheduleR/GiftGrntOrCapContriToOthOrgInd0false
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/ControlledOrganizationInd0false
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/DirectControllingNACd0N/A
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/DisregardedEntityName/BusinessNameLine1Txt0AMERICAN COLLEGE OF CLINICAL PHARMA
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/EIN0431183142
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/ExemptCodeSectionTxt0501C6
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/LegalDomicileStateCd0KS
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/PrimaryActivitiesTxt0PROMOTE QU
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/USAddress/AddressLine1Txt013000 W 87TH STREET PKWY
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/USAddress/CityNm0LENEXA
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/USAddress/StateAbbreviationCd0KS
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/USAddress/ZIPCd066215
IRS990ScheduleR/LoansOrGuaranteesFromOthOrgInd0false
IRS990ScheduleR/LoansOrGuaranteesToOtherOrgInd0false
IRS990ScheduleR/PaidEmployeesSharingInd0false
IRS990ScheduleR/PerformOfServicesByOtherOrgInd0false
IRS990ScheduleR/PerformOfServicesForOthOrgInd0false
IRS990ScheduleR/ReceiptOfIntAnntsRntsRyltsInd0false
IRS990ScheduleR/ReimbursementPaidByOtherOrgInd0false
IRS990ScheduleR/ReimbursementPaidToOtherOrgInd0false
IRS990ScheduleR/RentalOfFacilitiesToOthOrgInd0false
IRS990ScheduleR/RentalOfFcltsFromOthOrgInd0false
IRS990ScheduleR/SharingOfFacilitiesInd0false
IRS990ScheduleR/TransferFromOtherOrgInd0false
IRS990ScheduleR/TransferToOtherOrgInd0false
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/StatesWhereCopyOfReturnIsFldCd0MA
IRS990/SubjectToProxyTaxInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TempOrPermanentEndowmentsInd0false
IRS990/TerminateOperationsInd0false
IRS990/TotalAssetsBOYAmt01041494
IRS990/TotalAssetsEOYAmt01214923
IRS990/TotalAssetsGrp/BOYAmt01041494
IRS990/TotalAssetsGrp/EOYAmt01214923
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt076887
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0144506
IRS990/TotalFunctionalExpensesGrp/TotalAmt0221393
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt09500
IRS990/TotalLiabilitiesEOYAmt030000
IRS990/TotalLiabilitiesGrp/BOYAmt09500
IRS990/TotalLiabilitiesGrp/EOYAmt030000
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt01031994
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt01184923
IRS990/TotalProgramServiceExpensesAmt0144506
IRS990/TotalProgramServiceRevenueAmt0322192
IRS990/TotalRevenueGrp/ExclusionAmt033912
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt0355982
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt0389894
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt01041494
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt01214923
IRS990/TransactionWithControlEntInd0false
IRS990/TravelGrp/ProgramServicesAmt090
IRS990/TravelGrp/TotalAmt090
IRS990/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd0false
IRS990/UnrestrictedNetAssetsGrp/BOYAmt01031994
IRS990/UnrestrictedNetAssetsGrp/EOYAmt01184923
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt013000 WEST 87TH ST PARKWAY
IRS990/USAddress/CityNm0LENEXA
IRS990/USAddress/StateAbbreviationCd0KS
IRS990/USAddress/ZIPCd066215
IRS990/VotingMembersGoverningBodyCnt05
IRS990/VotingMembersIndependentCnt04
IRS990/WebsiteAddressTxt0WWW.PHARMACOTHERAPY.ORG
IRS990/WhistleblowerPolicyInd0true
ReturnHeader/BuildTS02016-02-25 16:41:14Z
ReturnHeader/BusinessOfficerGrp/PersonNm0MICHAEL S MADDUX
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0EXECUTIVE DIRECTOR
ReturnHeader/BusinessOfficerGrp/PhoneNum09134923311
ReturnHeader/BusinessOfficerGrp/SignatureDt02015-10-13
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0PHARMACOTHERAPY PUBLICATIONS INC
ReturnHeader/Filer/BusinessNameControlTxt0PHAR
ReturnHeader/Filer/EIN0042720360
ReturnHeader/Filer/PhoneNum09134923311
ReturnHeader/Filer/USAddress/AddressLine1Txt013000 WEST 87TH STREET PARKWAY
ReturnHeader/Filer/USAddress/CityNm0LENEXA
ReturnHeader/Filer/USAddress/StateAbbreviationCd0KS
ReturnHeader/Filer/USAddress/ZIPCd066215
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0481142819
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0BRIDGEBUILDER TAX LEGAL SERVICES PA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt09325 PFLUMM RD
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0LENEXA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0KS
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0662153347
ReturnHeader/PreparerPersonGrp/PhoneNum09134926008
ReturnHeader/PreparerPersonGrp/PreparationDt02015-10-22
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0KENNETH L COX
ReturnHeader/ReturnTs02015-10-26T16:20:39-05:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02014-01-01
ReturnHeader/TaxPeriodEndDt02014-12-31
ReturnHeader/TaxYr02014

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2014 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$1,214,923
Liabilities
$30,000
Net assets
$1,184,923
Revenue
$389,894
Expenses
$221,393
Net income
$168,501
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$5.24$0.23$5.01$0.65$0.58$0.07
2023Detailed filing. Detailed filing data is available for this year.$1.56$0.07$1.50$0.41$0.48$0.07
2022Detailed filing. Detailed filing data is available for this year.$1.47$0.10$1.37$0.43$0.43$0.01
2021Detailed filing. Detailed filing data is available for this year.$1.75$0.12$1.63$0.43$0.40$0.03
2020Detailed filing. Detailed filing data is available for this year.$1.61$0.15$1.47$0.37$0.35$0.02
2019Detailed filing. Detailed filing data is available for this year.$1.51$0.19$1.32$0.38$0.44$0.06
2018Detailed filing. Detailed filing data is available for this year.$1.42$0.22$1.20$0.41$0.43$0.03
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.64$0.25$1.38$0.39$0.38$0.01
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.37$0.02$1.35$0.45$0.30$0.15
2015XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.24$0.01$1.22$0.35$0.25$0.09
2014Detailed filing. Detailed filing data is available for this year.$1.21$0.03$1.18$0.39$0.22$0.17
2013Detailed filing. Detailed filing data is available for this year.$1.04$0.01$1.03$0.38$0.20$0.18
2012Summary only. Only limited summary data is available for this year.$0.89$0.10$0.79$0.42$0.70$0.28
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.08$0.05$1.03$1.00
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.24$0.19$1.05$0.98